Bluelinx v. Estate of David Williams
Opinion
RENDERED: MAY 26, 2023; 10:00 A.M.
NOT TO BE PUBLISHED
Commonwealth of Kentucky
Court of Appeals
NO. 2022-CA-1027-WC
BLUELINX APPELLANT
PETITION FOR REVIEW OF A DECISION v. OF THE WORKERS’ COMPENSATION BOARD ACTION NO. WC-19-64871
ESTATE OF DAVID WILLIAMS; TRACEY BURNS, EXECUTRIX; ELIJAH WILLIAMS, MINOR CHILD; HONORABLE W. GREG HARVEY, ADMINISTRATIVE LAW JUDGE; AND THE KENTUCKY WORKERS’ COMPENSATION BOARD APPELLEES
OPINION AFFIRMING
** ** ** ** **
BEFORE: CALDWELL, DIXON, AND TAYLOR, JUDGES.
DIXON, JUDGE: Bluelinx petitions for review of a Workers’ Compensation
Board (Board) decision affirming and remanding the Opinion, Award, and Order
rendered January 18, 2022, by the Administrative Law Judge (ALJ). After careful
review of the briefs, record, and law, we affirm.
BACKGROUND FACTS AND PROCEDURAL HISTORY
On February 18, 2021, Tracey Burns, Executrix, filed the underlying
Application for Resolution of a Claim – Injury seeking workers’ compensation
benefits, pursuant to KRS1 342.750, from Bluelinx on behalf of the Estate of David
Williams and his minor son.
The following facts are undisputed. Williams, an employee of
Bluelinx, suffered a work-related injury to his left ankle that necessitated surgery.
His pre-operative cardiac exam was normal, and out-patient surgery was performed
on October 25, 2019, without complications. Unfortunately, on October 27, 2019,2
he returned to the hospital by ambulance and subsequently died. The death
certificate cited complications of congestive heart failure (CHF) as the immediate
cause of death. At the time of his death, Williams was 50 years old with an
extensive medical history, including diagnoses of diabetes, obesity, CHF,
hypertension, hyperlipidemia, and deep venous thrombosis (DVT).
1 Kentucky Revised Statutes.
2 We note that Bluelinx’s brief records Williams’ date of death as October 28, 2019; however, this appears to be in error as it is refuted by the medical records, both experts’ statements, the testimony of Burns, and Bluelinx’s pleadings before the ALJ.
On the issue of causation, Dr. Steven S. Wunder, a physiatrist retained
by the estate, initially opined that “Williams’ cardiac condition did not pose an
immediate threat of death prior to [surgery and, g]iven the well-documented stable
condition of [Williams’ CHF], it is unlikely he would have succumbed to [CHF]
on October 27, 2019, or a reasonable time thereafter, if he had not undergone the
work-related surgery[.]” Dr. Wunder also noted that “[t]he rate of death doubles in
the perioperative time frame in those with a history of [CHF] and subsequent
noncardiac surgery.”
Bluelinx’s medical expert, Dr. John D. Corl, a practicing
interventional cardiologist, disputed that Williams had CHF, though he
acknowledged that Williams had been diagnosed with the condition during a 2014
hospitalization. Dr. Corl’s objection was based on his review of the
echocardiogram performed in 2014, the lack of confirmation by means of
catheterization following Williams’ subsequent diagnosis of liver abscesses, and
the fact that Williams, who was not being treated for the condition, had no
recurrent symptoms in the ensuing five years. Instead, concluding that there was
no direct causal relationship between the death and the surgery, Dr. Corl opined
that Williams suffered a sudden cardiac death caused by his known and
uncontrolled comorbid conditions – diabetes, hypertension, and obesity – as well
as probable sleep apnea.
In response, Dr. Wunder submitted the following rebuttal opinion:
I am surprised by the statements of Dr. Corl, as it is irrefutable that cardiac complications occur in those undergoing major, noncardiac surgery. In fact, cardiac complications are common after noncardiac surgery, and include sudden cardiac death. The single largest cause of perioperative patients death, I would agree with Dr. Corl, would be major adverse cardiac events. The number of patients undergoing noncardiac surgery is wide and is growing, and annually, 500,000 to 900,000 of these patients experience perioperative cardiac death, nonfatal myocardial infarction, or nonfatal cardiac arrest. Noncardiac surgery is associated with significant cardiac morbidity, mortality, and cost.
[]
Patients undergoing noncardiac surgery are at risk for major perioperative cardiac events. Perioperative myocardial infarction occurs primarily during the first three days after surgery, as was noted here. Some theorize that patients are receiving narcotic therapy and may not experience cardiac symptoms during a myocardial infarction. On studies which have examined perioperative cardiac death, authors attributed the cause to myocardial infarction in 66[%] of the cases and to arrhythmia or heart failure in 34[%] of the cases. It is felt that surgery with associated trauma, anesthesia, analgesia, intubation, extubation, pain, bleeding, and anemia all initiate inflammatory, hypercoagulable stress and hypoxic states, that are associated with perioperative elevations in troponin levels and mortality.
[]
It is irrefutable that general anesthesia can initiate inflammatory and hypercoagulable states, and a sudden cardiac death syndrome. The stress of surgery also involves increased levels of catecholamines and
increased stress hormone levels. Perioperative hypoxia can also lead to myocardial ischemia. It is felt that 75[%] of deaths after noncardiac surgery are due to cardiovascular complications, as outlined by Dr. Corl, and I am certain he must be aware of this. I have enclosed a review article from the New England Journal of Medicine [entitled Cardiac Complications in Patients undergoing Major Noncardiac Surgery (hereinafter “the Journal article”)] supporting that noncardiac surgery can precipitate complications such as death from cardiac causes, myocardial infarction or injury, cardiac arrest, or [CHF]. The number of patients receiving noncardiac surgery is increasing worldwide. More than 10 million adults worldwide have a major cardiac complication in the first 30 days after noncardiac surgery. As the [Journal] article points out, if perioperative death were considered as a separate category, it would rank as the third leading cause of death in the United States. I am surprised that Dr. Corl was not aware of that. Surgery initiates an inflammatory response, stress, hypercoagulability, activation of sympathetic nervous system, and hemodynamic compromise, all of which can trigger cardiac complications.
I am really confused as to what point Dr. Corl is trying to make. He seems to be arguing that [Williams] did not have [CHF]. He points out that no autopsy was done, and the cause of death was speculation. In addition to cardiac complications, sudden death can also be associated with [DVT] and pulmonary emboli, and [Williams] had a history of DVT already. Whichever complication his cause of death is attributed to, ([CHF] or pulmonary embolism), they occur at an increased frequency in the perioperative state. There is no way that Dr. Corl can make the statement that there was no direct causal relationship between [Williams’] noncardiac, left ankle surgery on October 25, 2019, and his death on October 27, 2019. Sudden cardiac death is a known complication of noncardiac surgery.
On January 18, 2022, the ALJ returned an opinion examining the
merits of the experts’ competing opinions.
A reading of the totality of the evidence is important. The [ALJ] interprets Dr. Wunder’s opinion to be that Williams’ surgery resulted in a cardiac event that caused his death. Dr. Corl also opines a cardiac event occurred that caused Williams[’] death. However, he is of the opinion that the surgery did not result in or cause the cardiac event. Dr. Corl reasoned that events occur to all persons who die from sudden cardiac death but that does not mean that those events are causative.
Free access — add to your briefcase to read the full text and ask questions with AI
Bluelinx v. Estate of David Williams (Bluelinx v. Estate of David Williams) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.